European society for medical oncology (ESMO) annual meeting 2024: key developments in the treatment paradigm for metastatic colorectal cancer

17 Dec 2024Oncology

Adiya Ualiyeva

This content is sponsored. It is intended for healthcare professionals only.

ONCOLOGY Medical writer: | Last updated: | In: Article Keywords Colorectal cancer (CRC) is a substantial healthcare burden globally, with over 1.9 million new cases and over 930,000 deaths in 2020. Metastatic CRC (mCRC) has a particularly poor prognosis, with a 5-year survival rate of only 14%. Here

Oncology European society for medical oncology (ESMO) annual meeting 2024: key developments in the treatment paradigm for metastatic colorectal cancer

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.